Cat. No.: HY-15269

PP30

Customer Review

Based on 1 Customer Validation

PP30 is a potent, selective, ATP-competitive mTOR inhibitor with an IC₅₀ of 80 nM. PP30 blocks insulin-stimulated phosphorylation of Akt at residues S473 and T308, preventing the full activation of Akt. PP30 is applicable for cancer research.

For research use only. We do not sell to patients.

Purity: 98.01%
CAS No.: 1092788-09-4
Formula: C₁₈H₁₉N₇OS
Molecular Weight:381.45

Storage:

4°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

PP30 Chemical Structure

CAS No.: 1092788-09-4

Size

Price

Stock

Quantity

Amount: USD 0.00

* Please select Quantity before adding items.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- IC₅₀ & Target
- In Vitro
Chemical Information
Solvent & Solubility
- In Vitro
Purity & Documentation
References
Help & FAQs
Classifications
Bioz

Biological Activity

Description

IC₅₀ & Target^[1]

p110δ

0.99 μM (IC₅₀)

p110γ

0.68 μM (IC₅₀)

p110α

3 μM (IC₅₀)

p110β

5.8 μM (IC₅₀)

mTOR

80 nM (IC₅₀)

All mTOR Isoforms :

All Akt Isoforms :

All PI3K Isoforms :

In Vitro

PP30 is a selective mTOR active-site inhibitor with an in vitro IC₅₀ value of 80 nM, and it exhibits only extremely weak activity against other members of the PI3K family as well as some protein kinases including PKCα and PKCβ^[1].
PP30 (0.04-10 μM; pre-incubated prior to insulin stimulation) inhibits insulin-induced phosphorylation of Akt at the S⁴⁷³ and T³⁰⁸ sites in L6 myotubes, with a stronger inhibitory potency against phosphorylation at the S⁴⁷³ site^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis^[1]

Cell Line:

L6 myotubes
Concentration:

0.04-10 μM
Incubation Time:

pre-incubated prior to 3 min insulin stimulation
Result:

Inhibited insulin-stimulated phosphorylation of Akt at S473.
Required higher concentrations to inhibit Akt phosphorylation at T308 compared to S473.

Chemical Information

CAS No. 1092788-09-4
Appearance Solid
Molecular Weight 381.45
Formula C₁₈H₁₉N₇OS
Color White to off-white
SMILES

NC1=C2C(N(C(C)C)N=C2C3=CC(C(NC4=NCCS4)=O)=CC=C3)=NC=N1
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

4°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Solvent & Solubility

In Vitro:

DMSO : 101 mg/mL (264.78 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

2.6216 mL

13.1079 mL

26.2158 mL

5 mM

0.5243 mL

2.6216 mL

5.2432 mL

10 mM

0.2622 mL

1.3108 mL

2.6216 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Purity & Documentation

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (283 KB)
SDS (252 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Feldman ME, et al. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol. 2009;7(2):e38. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	2.6216 mL	13.1079 mL	26.2158 mL	65.5394 mL
	5 mM	0.5243 mL	2.6216 mL	5.2432 mL	13.1079 mL
	10 mM	0.2622 mL	1.3108 mL	2.6216 mL	6.5539 mL
	15 mM	0.1748 mL	0.8739 mL	1.7477 mL	4.3693 mL
	20 mM	0.1311 mL	0.6554 mL	1.3108 mL	3.2770 mL
	25 mM	0.1049 mL	0.5243 mL	1.0486 mL	2.6216 mL
	30 mM	0.0874 mL	0.4369 mL	0.8739 mL	2.1846 mL
	40 mM	0.0655 mL	0.3277 mL	0.6554 mL	1.6385 mL
	50 mM	0.0524 mL	0.2622 mL	0.5243 mL	1.3108 mL
	60 mM	0.0437 mL	0.2185 mL	0.4369 mL	1.0923 mL
	80 mM	0.0328 mL	0.1638 mL	0.3277 mL	0.8192 mL
	100 mM	0.0262 mL	0.1311 mL	0.2622 mL	0.6554 mL

Keywords

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Product Name:
CAS No.:
Species:
Purity:
Quantity:

PP30

Kinase Inhibitor Library

PI3K/Akt/mTOR Compound Library

Stem Cell Signaling Compound Library

Anti-Cancer Compound Library

Autophagy Compound Library

Anti-Aging Compound Library

Antioxidant Compound Library

Differentiation Inducing Compound Library

Reprogramming Compound Library

Oxygen Sensing Compound Library

Glycolysis Compound Library

Cytoskeleton Compound Library

Glutamine Metabolism Compound Library

Anti-Breast Cancer Compound Library

Anti-Lung Cancer Compound Library

Anti-Pancreatic Cancer Compound Library

Anti-Blood Cancer Compound Library

Anti-Cancer Metabolism Compound Library

Anti-Obesity Compound Library

Angiogenesis-Related Compound Library

Glucose Metabolism Compound Library

Anti-Liver Cancer Compound Library

Anti-Colorectal Cancer Compound Library

Anti-Prostate Cancer Compound Library

Anti-Pulmonary Fibrosis Compound Library

Cancer Stem Cells Compound Library

Heterocyclic Compound Library

Pain-Related Compound Library

Mitochondrial Protection Compound Library

Membrane Protein-targeted Compound Library

Highly Selective Inhibitors Library

Serine/Threonine Kinase Inhibitor Library

Anti-Hematopathy Compound Library

Anti-Ovarian Cancer Compound Library

Multi-Target Compound Library

Radioprotector Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Bioactive Compound Library

Anti-Gastric Cancer Compound Library

Anti-Fibrosis Compound Library

Anti-Brain Cancer Compound Library

Protein Kinase Compound Library

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

Cell Proliferation Compound Library

High-Throughput Bioactive Compound Library

Lactylation Compound Library

All mTOR Isoforms

All Akt Isoforms

All PI3K Isoforms

Biological Activity

Chemical Information

Solvent & Solubility

Purity & Documentation

References

Help & FAQs

Complete Stock Solution Preparation Table

PP30 Related Classifications

HY-15269 Related Classifications